EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: Interactions between two members of the tet family, EWS and HTAF(II)68, and subunits of TFIID and RNA polymerase II complexes

Molecular and Cellular Biology

Volumn 18, Issue 3, 1998, Pages 1489-1497

  Bertolotti, Anne ^a   Melot, Thomas ^b   Acker, Joël ^a   Vigneron, Marc ^a   Delattre, Olivier ^b   Tora, Laszlo ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RNA POLYMERASE II; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CHROMOSOME TRANSLOCATION; ENZYME ACTIVITY; ENZYME STRUCTURE; EWING SARCOMA; GENETIC TRANSCRIPTION; NEUROECTODERM TUMOR; PRIORITY JOURNAL;

EID: 0031935157     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.3.1489     Document Type: Article

References (39)

1. Acker, J., M. de Graaff, I. Cheynel, V. Khazak, C. Kedinger, and M. Vigneron. 1997. Interactions between the human RNA polymerase II subunits. J. Biol. Chem. 272:16815-16821.
2. Bailly, R. A., R. Bosselut, J. Zucman, F. Cormier, O. Delattre, M. Roussel, G. Thomas, and J. Ghysdael. 1994. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11: 22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14:3230-3241.
3. Bertolotti, A., Y. Lutz, D. J. Heard, P. Chambon, and L. Tora. 1996. hTAFII68 a novel RNA/SSDNA-hinding protein with homology to the prooncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 15:5022-5031.
4. Besse, S., M. Vigneron, E. Pichard, and F. Puvlon-Dutilleul. 1995. Synthesis and maturation of viral transcripts in herpes simplex virus type 1 infected HeLa cells: the role of interchromatin granules. Gene Expr. 4:143-161.
5. Brou, C., S. Chaudhary, I. Davidson, Y. Lutz, J. Wu, J. M. Egly, L. Tora, and P. Chambon. 1993. Distinct TFIID complexes mediate the effect of different transcriptional activators. EMBO J. 12:489-499.
6. Burd, C. G., and G. Dreyfuss. 1994. Conserved structures and diversity of functions of RNA-binding proteins. Science 265:615-621.
7. Crozat, A., P. Aman, N. Mandahl, and D. Ron. 1993. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640-644.
8. Delattre, O., J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, et al. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165.
9. II100 are required for functional interaction with transcription factor TFIIFb (RAP30) and incorporation into the TFIID complex. EMBO J. 15:3702-3712.
10. Fraser, R. A., M. Rossignol, D. J. Heard, J. M. Egly, and P. Chambon. 1997. SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase. J. Biol. Chem. 272:7122-7126.
11. Gerard, M., L. Fischer, V. Moncollin, J. M. Chipoulet, P. Chambon, and J. M. Egly. 1991. Purification and interaction properties of the human RNA polymerase B(II) general transcription factor BTF2. J. Biol. Chem. 266:20940-20945.
12. Giovannini, M., J. A. Biegel, M. Serra, J. Y. Wang, Y. H. Wei, L. Nycum, B. S. Emanuel, and G. A. Evans. 1994. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. J. Clin. Invest. 94:489-496.
13. Hurst, H. C. 1996. Transcription factors as drug targets in cancer. Fur. J. Cancer 32A:1857-1863.
14. Immanuel, D., H. Zinszner, and D. Ron. 1995. Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II. Mol. Cell. Biol. 15:4562-4571.
15. Jacq, X., C. Brou, Y. Lutz, I. Davidson, P. Chambon, and L. Tora. 1994. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79:107-117.
16. Labelle, Y., J. Zucman, G. Stenman, L. G. Kindblom, J. Knight, C. Turc-Carel, B. Dockhorn-Dworniczak, N. Mandahl, C. Desmaze, M. Peter, et al. 1995. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum. Mol. Genet. 4:221-226.
17. Ladanyi, M. 1995. The emerging molecular genetics of sarcoma translocations. Diagn. Mol. Pathol. 4:162-173.
18. Lessnick, S. L., B. S. Braun, C. T. Denny, and W. A. May. 1995. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene 10:423-431.
19. Lewin, B. 1991. Oncogenic conversion by regulatory changes in transcription factors. Cell 64:303-312.
20. May, W. A., M. L. Gishizky, S. L. Lessnick, L. B. Lunsford, B. C. Lewis, O. Delattre, J. Zucman, G. Thomas, and C. T. Denny. 1993. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. USA 90:5752-5756.
21. Melot, T., N. Gruel, A. Doubeikovski, N. Sevenet, J. L. Teillaud, and O. Delattre. 1997. Production and characterization of mouse monoclonal antibodies to wild-type and Oncogenic FLI-1 proteins. Hybridoma 16:457-464.
22. Meyers, S., and S. W. Hiebert. 1995. Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. Crit. Rev. Eukaryotic Gene Expr. 5:365-383.
23. Nagai, K., C. Oubridge, T. H. Jessen, J. Li, and P. R. Evans. 1990. Crystal structure of the RNA-binding domain of the U1 small nuclear ribonucleoprotein A. Nature 348:515-520.
24. Ohno, T., M. Ouchida, L. Lee, Z. Gatalica, V. N. Rao, and E. S. Reddy. 1994. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9:3087-3097.
25. Ohno, T., V. N. Rao, and E. S. Reddy. 1993. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res. 53:5859-5863.
26. O'Reilly, D. R., L. K. Miller, and V. A. Luckow. 1992. Baculovirus expression vectors. W. H. Freeman, New York, N.Y.
27. Peter, M., J. Couturier, H. Pacquement, J. Michon, G. Thomas, H. Magdelenat, and O. Delattre. 1997. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14:1159-1164.
28. Petermann, R., B. M. Mossier, and H. Kovar. Personal communication.
29. Plougastel, B., J. Zucman, M. Peter, G. Thomas, and O. Delattre. 1993. Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics 18:609-615.
30. Rabbitts, T. H., A. Forster, R. Larson, and P. Nathan. 1993. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet. 4:175-180.
31. Roeder, R. G. 1996. Nuclear RNA polymerase: role of general initiation factors and cofactors in eukaryotic transcription. Methods Enzymol. 273:165-171.
32. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
33. Stolow, D. T., and S. R. Haynes. 1995. Cabeza, a Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. Nucleic Acids Res. 23:835-843.
34. Turc-Carel, C., A. Aurias, F. Mugneret, S. Lizard, I. Sidaner, C. Volk, J. P. Thiery, S. Olschwang, I. Philip, M. P. Berger, et al. 1988. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet. Cytogenet. 32:229-238.
35. Urano, F., A. Umezawa, W. Hong, H. Kikuchi, and J. Hata. 1996. A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem. Biophys. Res. Commun. 2:608-612.
36. Verrijzer, C. P., and R. Tjian. 1996. TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem. Sci. 21:338-342.
37. Wasylyk, B., S. L. Hahn, and A. Giovane. 1993. The Ets family of transcription factors. Eur. J. Biochem. 211:7-18.
38. Yankulov, K., J. Blau, T. Purton, S. Roberts, and D. L. Bentley. 1994. Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell 77:749-759.
39. Zinszner, H., R. Albalat, and D. Ron. 1994. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 8:2513-2526.